Aquatic Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,731
Closed -$9.33M 1741
2025
Q4
$9.33M Buy
38,731
+14,167
+58% +$3.62M 0.27% 91
2025
Q3
$6.72M Buy
24,564
+12,642
+106% +$3.45M 0.12% 204
2025
Q2
$3.08M Buy
11,922
+5,995
+101% +$1.43M 0.06% 354
2025
Q1
$1.33M Sell
5,927
-42,640
-88% -$9.95M 0.03% 525
2024
Q4
$11.1M Buy
+48,567
New +$11.7M 0.3% 86
2023
Q4
Sell
-75,300
Closed -$11.1M 1579
2023
Q3
$11.1M Buy
75,300
+45,200
+150% +$8.17M 0.46% 56
2023
Q2
$6.58M Buy
30,100
+19,700
+189% +$4.39M 0.36% 66
2023
Q1
$2.28M Sell
10,400
-15,800
-60% -$3.43M 0.14% 166
2022
Q4
$5.45M Buy
+26,200
New +$5.76M 0.4% 55
2022
Q1
Sell
-600
Closed -$156K 1455
2021
Q4
$156K Buy
+600
New +$156K 0.3% 56

Other funds holding RMD

Aquatic Capital Management's RMD Position: Q1 2026 in Review

Aquatic Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 38,731 shares — an estimated $9.33M sold.

Aquatic Capital Management first reported a position in RMD in Q4 2021 and held it in 10 quarters. The position peaked at $11.1M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aquatic Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 38,731 ResMed shares in Q1 2026, an estimated $9.33M.
  • Aquatic Capital Management first reported a position in ResMed in Q4 2021 and held it in 10 quarters.
  • Aquatic Capital Management's ResMed position peaked at $11.1M in Q3 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.